retatrutide for obesity vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness A New Obesity Drug Delivered

For those employers looking for alternative support programs, Noom is introducing a member discount offering that ensures affordable access to branded and low-cost, non-branded GLP-1 medications

"Obesity as pleiotropic risk state for metabolic and mental health throughout life." Translational Psychiatry 13.1 (2023): 175.

Return your GLP-1 appetite suppressant within 30 days for a full refund

In contrast, the control group comprised patients with obesity who did not receive a GLP-1 prescription during the study timeframe

Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

CMS is then empowered to effectuate these initiatives, working with providers and pharmacies to develop the logistics necessary to make these drugs available to Medicare patients